Literature DB >> 3490666

Molecular cloning and primary nucleotide sequence analysis of a distinct human immunodeficiency virus isolate reveal significant divergence in its genomic sequences.

S M Desai, V S Kalyanaraman, J M Casey, A Srinivasan, P R Andersen, S G Devare.   

Abstract

In an effort to evaluate data on genomic relatedness among the various human immunodeficiency viruses (HIVs), we have molecularly cloned a virus isolate designated HIV (CDC-451). Preliminary characterization of the HIV (CDC-451) clone indicated that the restriction enzyme map was distinct from those of other known HIV isolates. Analysis of the primary nucleotide sequence of the regions encoding the structural proteins and comparison with sequences known for other HIV isolates indicated substantial differences for HIV (CDC-451). The sequences encoding the group-specific antigen gene, although they showed some variation, were conserved to a greater extent than were those encoding envelope proteins. In the envelope gene sequences, most of the changes (up to 24.5% divergence) were located in the amino-terminal region encoding a glycoprotein with a Mr of 120,000. The carboxyl-terminal region, encoding a protein of Mr 41,000, was more highly conserved. The variation in the sequences encoding envelope proteins may have important implications for the antigenic properties and/or pathogenicity of the disease and for its detection and ultimate eradication.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3490666      PMCID: PMC386932          DOI: 10.1073/pnas.83.21.8380

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Type-C and type-D primate retrovirus envelope glycoproteins bind common cellular receptor sites.

Authors:  C F Moldow; R S Kauffman; S G Devare; J R Stephenson
Journal:  Virology       Date:  1979-10-30       Impact factor: 3.616

2.  Biochemical and immunological properties of gag genecoded structural proteins of endogenous tyep C RNA tumor viruses of diverse mammalian species.

Authors:  J R Stephenson; R K Reynolds; S G Devare; F H Reynolds
Journal:  J Biol Chem       Date:  1977-11-10       Impact factor: 5.157

3.  Membrane receptors for murine leukemia viruses: characterization using the purified viral envelope glycoprotein, gp71.

Authors:  J DeLarco; G J Todaro
Journal:  Cell       Date:  1976-07       Impact factor: 41.582

4.  Evolutionary relationships between gag gene-coded proteins of murine and primate endogenous type C RNA viruses.

Authors:  M Barbacid; J R Stephenson; S A Aaronson
Journal:  Cell       Date:  1977-04       Impact factor: 41.582

5.  Nucleotide sequence analysis of the long terminal repeat of integrated simian sarcoma virus: evolutionary relationship with other mammalian retroviral long terminal repeats.

Authors:  S G Devare; E P Reddy; J D Law; S A Aaronson
Journal:  J Virol       Date:  1982-06       Impact factor: 5.103

6.  Radioimmunoassay of mammalian type C viral proteins. I. Species specific reactions of murine and feline viruses.

Authors:  E M Scolnick; W P Parks; D M Livingston
Journal:  J Immunol       Date:  1972-09       Impact factor: 5.422

7.  Genomic changes associated with antigenic variation of visna virus durig persistent infection.

Authors:  J E Clements; F S Pedersen; O Narayan; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

8.  Structural proteins of mammalian oncogenic RNA viruses: murine leukemia virus neutralization by antisera prepared against purified envelope glycoprotein.

Authors:  R A Steeves; M Strand; J T August
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Abelson murine leukemia virus: molecular cloning of infectious integrated proviral DNA.

Authors:  A Srinivasan; E P Reddy; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

View more
  20 in total

1.  K-tuple frequency in the human genome and polymerase chain reaction.

Authors:  R Griffais; P M André; M Thibon
Journal:  Nucleic Acids Res       Date:  1991-07-25       Impact factor: 16.971

2.  Mutation pattern of human immunodeficiency virus gene.

Authors:  E N Moriyama; Y Ina; K Ikeo; N Shimizu; T Gojobori
Journal:  J Mol Evol       Date:  1991-05       Impact factor: 2.395

3.  In vitro selection of variants of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine.

Authors:  Q Gao; Z X Gu; M A Parniak; X G Li; M A Wainberg
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

4.  Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboons.

Authors:  N L Haigwood; P L Nara; E Brooks; G A Van Nest; G Ott; K W Higgins; N Dunlop; C J Scandella; J W Eichberg; K S Steimer
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

5.  Epitope mapping of the human immunodeficiency virus type 1 gp120 with monoclonal antibodies.

Authors:  D Dowbenko; G Nakamura; C Fennie; C Shimasaki; L Riddle; R Harris; T Gregory; L Lasky
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

6.  Generation of hybrid human immunodeficiency virus by homologous recombination.

Authors:  A Srinivasan; D York; R Jannoun-Nasr; S Kalyanaraman; D Swan; J Benson; C Bohan; P A Luciw; S Schnoll; R A Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

7.  Extension of mismatched 3' termini of DNA is a major determinant of the infidelity of human immunodeficiency virus type 1 reverse transcriptase.

Authors:  F W Perrino; B D Preston; L L Sandell; L A Loeb
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

8.  Association of ERK2 mitogen-activated protein kinase with human immunodeficiency virus particles.

Authors:  C Cartier; M Deckert; C Grangeasse; R Trauger; F Jensen; A Bernard; A Cozzone; C Desgranges; V Boyer
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

9.  Evolutionary origin of human and simian immunodeficiency viruses.

Authors:  T Gojobori; E N Moriyama; Y Ina; K Ikeo; T Miura; H Tsujimoto; M Hayami; S Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

10.  Broadly neutralizing antibodies targeted to mucin-type carbohydrate epitopes of human immunodeficiency virus.

Authors:  J E Hansen; C Nielsen; M Arendrup; S Olofsson; L Mathiesen; J O Nielsen; H Clausen
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.